2025
SJR Q1
JCR Q2 · 4,2
OA
19 matched articles
SCIE
Journal detail
Cancer Research and Treatment
- Publisher
- Korean Cancer Association
- Country
- South Korea · Asiatic Region
- Type
- journal
- ISSN
-
1598299820059256
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,462
- Quartile Q1
- H-Index 68
- Cites/doc 4,04
- Docs (3y) 368
- Cites (3y) 1.580
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,2
- 5Y JIF 4,3
- JCI 0,94
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Oncology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,462 | 4,2 | 4,3 | 0,94 | Q2 | 68 |
| 2024 | Q1 | Q2 | 1,434 | 3,8 | 3,8 | 1,03 | Q1 | 64 |
| 2023 | Q1 | Q2 | 1,254 | 4,1 | 4 | 1,1 | Q1 | 64 |
| 2022 | Q1 | Q2 | 1,341 | 4,6 | 4,2 | 0,97 | Q2 | 64 |
| 2021 | Q1 | Q2 | 1,359 | 5 | 4,3 | 1 | Q2 | 64 |
| 2020 | Q1 | Q2 | 1,668 | 4,7 | 3,9 | 1 | Q2 | 64 |
| 2019 | Q1 | Q2 | 1,348 | 3,8 | 3,2 | 0,97 | Q2 | 64 |
| 2018 | — | Q2 | — | 3,4 | 3,2 | 0,94 | Q2 | — |
| 2017 | Q1 | Q2 | 1,385 | 3,2 | 3,2 | 0,93 | Q2 | 64 |
| 2016 | Q1 | Q2 | 1,41 | 3,8 | 3,5 | — | — | 64 |
| 2015 | Q1 | Q2 | 1,859 | 4,2 | 3,1 | — | — | 64 |
| 2014 | Q2 | Q2 | 1,279 | 3,3 | 2,4 | — | — | 64 |
| 2013 | Q2 | Q2 | 1,238 | 3 | — | — | — | 64 |
| 2012 | Q2 | Q3 | 0,706 | 2 | — | — | — | 64 |
| 2011 | — | — | — | — | — | — | — | 64 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 108/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q1 | 101/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q1 | 92/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 89/241 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 92/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 101/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 97/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 97/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 110/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 75/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 54/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 82/211 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 83/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 130/197 |